Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 530,000 | 268,000 | 207,000 | 352,000 | 371,000 |
| Receivables | 1,278,000 | 1,232,000 | 1,217,000 | 1,197,000 | 1,243,000 |
| Inventories | 842,000 | 851,000 | 884,000 | 911,000 | 898,000 |
| Income taxes - deferred | 496,000 | 431,000 | 433,000 | 483,000 | 406,000 |
| TOTAL | $3,498,000 | $3,102,000 | $3,022,000 | $3,173,000 | $3,111,000 |
| Non-Current Assets | |||||
| PPE Net | 1,524,000 | 1,537,000 | 1,564,000 | 1,624,000 | 1,632,000 |
| Intangibles | 11,579,000 | 11,729,000 | 12,262,000 | 11,878,000 | 12,723,000 |
| Other Non-Current Assets | 395,000 | 395,000 | 306,000 | 223,000 | 352,000 |
| TOTAL | $13,498,000 | $13,661,000 | $14,132,000 | $13,725,000 | $14,707,000 |
| Total Assets | $16,996,000 | $16,763,000 | $17,154,000 | $16,898,000 | $17,818,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 605,000 | 4,000 | 4,000 | 3,000 | 4,000 |
| Accounts payable and accrued liabilities | 251,000 | 206,000 | 232,000 | 228,000 | 263,000 |
| Accrued Expenses | 1,365,000 | 1,186,000 | 1,284,000 | 1,325,000 | 1,325,000 |
| Other current liabilities | 256,000 | 240,000 | 252,000 | 259,000 | 202,000 |
| TOTAL | $2,477,000 | $1,636,000 | $1,772,000 | $1,815,000 | $1,794,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,647,000 | 4,250,000 | 4,252,000 | 4,252,000 | 4,253,000 |
| Other Non-Current Liabilities | 2,558,000 | 2,664,000 | 2,547,000 | 2,298,000 | 2,240,000 |
| TOTAL | $7,916,000 | $8,624,000 | $8,512,000 | $8,255,000 | $8,296,000 |
| Total Liabilities | $10,393,000 | $10,260,000 | $10,284,000 | $10,070,000 | $10,090,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,342,874 | 1,550,351 | 1,357,426 | 1,372,984 | 1,418,982 |
| Common Shares | 16,000 | 16,000 | 15,000 | 15,000 | 15,000 |
| Retained earnings | -8,673,000 | -8,803,000 | -8,449,000 | -8,510,000 | -7,846,000 |
| Other shareholders' equity | 82,000 | 45,000 | -33,000 | -112,000 | -87,000 |
| TOTAL | $6,603,000 | $6,503,000 | $6,870,000 | $6,828,000 | $7,728,000 |
| Total Liabilities And Equity | $16,996,000 | $16,763,000 | $17,154,000 | $16,898,000 | $17,818,000 |